Eligibility for Alirocumab or Evolocumab Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 Mg/Dl Despite Maximal Tolerated Cholesterol Lowering Therapy
Authors:
- Naila GoldenbergNGNaila Goldenberg
- Kevin LeeKLKevin Lee
- Marloe PrinceMPMarloe Prince
- Vybhav JettyVJVybhav Jetty
- Ashwin KumarAKAshwin Kumar
- Michael GoldenbergMGMichael Goldenberg
- Parth ShahPSParth Shah
- Ping WangPWPing Wang
- Charles GlueckCGCharles Glueck
- 1 May 2017
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 11 (3) , 786